Table 1.
Comparison of decompensated events and death between with and without SPSS.
| First author (year) | Study design | Enrollment period | Target population | No. of pts. in total | No. of pts. with shunt | Radiological evaluation | HE | Gastrointestinal bleeding | Ascites | Portal vein thrombosis | Death | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| With shunt | Without shunt | With shunt | Without shunt | With shunt | Without shunt | With shunt | Without shunt | With shunt | Without shunt | |||||||
| Qi et al. (2017) [20] | Cross-sectional | Jun. 2012–Dec. 2013 | LC | 105 | 11 | CT or MRI | 2 (18.2%) | 4 (4.7%) | 0 (0%) | 17 (18.1%) | 7 (63.6%) | 52 (55.3%) | NA | NA | 0 (0%) | 4 (4.3%) |
| He et al. (2018) [21] | Cohort | Jan. 2004–Dec. 2014 | LC | 903 | 188 | Angiography | 89 (47.3%) | 278 (39.0%) | 175 (93.1%) | 623 (87.1%) | 126 (67.0%) | 606 (84.7%) | NA | NA | 68 (36.2%) | 311 (43.5%) |
| Saks et al. (2018) [22] | Cohort | Jan. 2001–Feb. 2016 | LT | 741 | 173 | CT or MRI | NA | NA | 25% | 28% | 43% | 59% | 13% | 4% | 35% | 42% |
| Simón-Talero et al. (2018) [7] | Cohort | 2010–2015 | LC | 1729 | 1036 | CT or MRI | L: 32% | 8% | L: 25% | 11% | L: 57% | 32% | L: 18% | 5% | L: 38% | 32% |
| S: 19% | S: 26% | S: 55% | S: 10% | S: 28% | ||||||||||||
| Allard et al. (2021) [23] | Cohort | Jan. 2003–Dec. 2016 | LT | 335 | 197 | CT | NA | NA | NA | NA | NA | NA | 36 (18.3%) | 13 (9.5%) | 7 (4.0%) | 6 (4.9%) |
| Nardelli et al. (2021) [12] | Cohort | Mar. 2015–Jul. 2019 | LC | 222 | 141 | CT | 28 (20%) | 11 (13%) | 31 (22%) | 13 (16%) | 84 (60%) | 47 (58%) | 22 (16%) | 3 (4%) | SPSS has a higher mortality | |
| Rathi et al. (2021) [24] | Cohort | 2009–2017 | LC | 127 | 89 | CT or MRI | Large SPSS had a higher risk of HE | NA | NA | 12 (14%) | 3 (8%) | 27 (30%) | 3 (8%) | NA | NA | |
| Yi et al. (2021) [9] | Cohort | Dec. 2014–Aug. 2019 | LC | 122 | 37 | CT or MRI | 4 (10.8%) | 6 (7.1%) | 25 (67.6%) | 67 (78.8%) | 23 (62.2%) | 50 (58.8%) | 13 (35.1%) | 27 (31.8%) | 7 (18.9%) | 4 (4.7%) |
| Dajti et al. (2022) [6] | Cohort | Jan. 2014–Dec. 2017 | ACLD | 235 | 141 | CT or MRI | 9 (6.4%) | 3 (3.2%) | 22 (15.6%) | 5 (5.3%) | 33 (23.4%) | 13 (13.9%) | 20 (14.2%) | 3 (3.2%) | 22 (15.6%) | 9 (9.6%) |
Pts., patients; LC, liver cirrhosis; LT, liver transplantation; SPSS, spontaneous portosystemic shunt; SSRS, spontaneous splenorenal shunt; HE, hepatic encephalopathy; CT, computed tomography; MRI, magnetic resonance imaging; L, large SPSS; S, small SPSS; ACLD, advanced chronic liver disease.